Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H34N8 |
Molecular Weight | 506.6446 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(NC2=CC=C3CC[C@@H](CCC3=C2)N4CCCC4)=NN1C5=NN=C6C(CCCC7=C6C=CC=C7)=C5
InChI
InChIKey=KXMZDGSRSGHMMK-VWLOTQADSA-N
InChI=1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1
Molecular Formula | C30H34N8 |
Molecular Weight | 506.6446 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:37:27 UTC 2023
by
admin
on
Sat Dec 16 09:37:27 UTC 2023
|
Record UNII |
0ICW2LX8AS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
452314
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
46215462
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
100000175775
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
FG-190
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
Bemcentinib
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
C121854
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL2023349
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
0ICW2LX8AS
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
DB12411
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
1037624-75-1
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
DTXSID70673109
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY | |||
|
10631
Created by
admin on Sat Dec 16 09:37:27 UTC 2023 , Edited by admin on Sat Dec 16 09:37:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
COMPETITIVE INHIBITOR
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |